Evidence map›Paper›PMID 42272767›Full record

ArticleJournal of multimorbidity and comorbidity

Prioritising and ranking methodological uncertainties in the design, conduct, and analysis of trials aiming to improve health outcomes for those living with multiple long-term conditions: A protocol for a modified Delphi study.

Ayat Ahmadi, Lisong Zhang, Natasha Bryant, Natalie Darko, Kamlesh Khunti, Sally J Singh, Sharon A Simpson, Susan M Smith, Rod S Taylor, Miles D Witham and 2 more

Abstract read
In one paragraph

Article in Journal of multimorbidity and comorbidity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ayat AhmadiDivision of Public Health and Epidemiology, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-8018-9784
Lisong ZhangDivision of Public Health and Epidemiology, University of Leicester, Leicester, UK.
Natasha BryantNIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Natalie DarkoNIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Kamlesh KhuntiNIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Sally J SinghNIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-9834-0366
Sharon A SimpsonPublic Health, School of Health and Well Being, University of Glasgow, Glasgow, UK.ORCID https://orcid.org/0000-0002-6219-1768
Susan M SmithDiscipline of Public Health and Primary Care, Trinity College, Dublin, Ireland.ORCID https://orcid.org/0000-0001-6027-2727
Rod S TaylorRobertson Centre for Biostatistics, School of Health and Well Being, University of Glasgow, Glasgow, UK.
Miles D WithamAGE Research Group, Translational and Clinical R esearch Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.ORCID https://orcid.org/0000-0002-1967-0990
Hannah YoungDiabetes Research Centre, University of Leicester, Leicester, UK.
Laura J GrayDivision of Public Health and Epidemiology, University of Leicester, Leicester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple long-term conditions (MLTCs), defined as the co-existence of two or more chronic health conditions, are increasingly prevalent across all age groups and disproportionately affect socioeconomically disadvantaged and ethnic minority populations. Trials targeting MLTCs face methodological challenges due to patient heterogeneity, variation in selection of conditions and limitations in design and analysis. These challenges may contribute to the lack of evidence to inform effective interventions for people with MLTCs. This study aims to systematically identify and prioritise key methodological uncertainties in the design, conduct and analysis of future trials aiming to improve health outcomes for people with MLTCs. Methods: We will conduct a four-round modified Delphi study involving key interest groups including methodologists, trialists, MLTC researchers, research funders, commissioners, regulators, people with MLTC lived experience and MLTC carers. The process will include two rounds of online questionnaires, one lived-experience meeting (in-person or virtual) and a final virtual consensus meeting. To promote inclusivity and diversity of input, participants may join at any stage. Responses from each round will be analysed and summarised to inform the next stage, with final priorities agreed through structured consensus voting. Expected Outcomes: This consensus study will produce a ranked list of methodological research uncertainties to guide future research and clinical trial design, conduct and analysis in MLTCs. Findings will be disseminated through a facilitated online dissemination workshop, academic channels and targeted public engagement activities to support inclusive and relevant MLTC research.

Indexed as

clinical trialconsensusmultimorbidityresearch design

Identifiers

PMID42272767
PMCPMC13247373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.